In our June issue of Pharmaceutical Executive
FEATURES
Cover Story
Pharm Exec's Top 50 Pharma Companies 2018
Pharmaceutical Executive
Pharm Exec's 18th annual listing of the top biopharma players shows that most of the familiar placeholders are holding their ground as they weigh a changing business climate with new opportunities for growth. |
ADVERTISEMENT
Evolving Life Sciences Quality Management: Keeping Up with the New Reality
Thursday, June 21, 2018 at 1pm EDT | 12pm CDT | 10am PDT
 Register now |
Interview
Amryt Pharma's Joe Wiley
Julian Upton
Pharm Exec speaks with Joe Wiley, CEO of the UK's Amryt Pharma, who is steering a road-less-traveled path for a small pharma—building a sustainable, commercial infrastructure first, with the hopes of accelerating new rare disease drugs to the market. |
ADVERTISEMENT
Combination Therapies in Oncology: The Benefits of Integrated Insights
On Demand
 Learn more |
Market Access
The Midterm Elections: Prescription Price Policy
Sudip Parikh
There is no magic bullet that will dramatically impact drug pricing to everybody's liking. But a stepwise approach involving a series of reforms, including taking advantage of the next midterm elections, could point the path toward a solution. |
ADVERTISEMENT
Patient Engagement in Clinical Trials
On Demand
 Learn more |
Sales & Marketing
Leveraging Lab Data in Advent of Personalized Marketing
Melissa Leonhauser
Laboratory testing has become a critical access point for sales teams in the age of personalized medicine. |
ALSO IN THIS ISSUE
Insights for the Win
Lisa Henderson
Editor-in-Chief Lisa Henderson reports on the takeaways from last month's annual gathering of the Pharm Exec Editorial Advisory Board …Read more
US Maps Strategy to Reform Drug Pricing
Jill Wechsler
Azar and Gottlieb out front in revising rebates, restructuring Medicare, and promoting competition …Read more
| <
ADVERTISEMENT
Capturing The Attention of Investors: How to create a compelling value story
On Demand
 Learn more |
|
Can Trump Plan Serve as a Model for What Ails Europe?
Reflector
Weighing the crossover effect of US's new pricing blueprint …Read more
Asembia 2018: User–Friendly Urgency
Michelle Maskaly
A look at the possibilities for high tech and the patient journey in specialty pharma, as discussed at the recent Asembia conference in Las Vegas. …Read more
|
| |
| WEBCASTS |
| Evolving Life Sciences Quality Management: Keeping Up with the New Reality |
| Combination Therapies in Oncology: The Benefits of Integrated Insights |
| Patient Engagement in Clinical Trials |
Capturing the attention of investors: How to create a compelling value story
|
HCP Multichannel Marketing – What Does Great Look Like?
|
CRO Consolidation: A Sinister Threat or Windfall for Pharma?
|
Using Artificial Intelligence to Drive Innovation in Life Sciences
|
The Rare Disease Revolution
|
